Searched for
LUPIN PHARMA CANADA LTD
Stocks in news: Fractal Analytics, RIL, Cochin Shipyard, Trent, BritanniaMarkets saw volatility but recovered modestly on Monday, with analysts maintaining a cautious outlook. Several stocks like Fractal Analytic...- Lupin signs supply deal to launch antidepressant in CanadaDrug firm Lupin has partnered with Spektus Pharma. They will commercialise the antidepressant DeslaFlex in Canada. This collaboration combi...
- Lupin signs $50 million licensing deal with Zentiva to commercialise Certolizumab Pegol across global marketsLupin Ltd has partnered with Zentiva Group to commercialize its biosimilar 'Certolizumab Pegol' across global markets. The agreement grants...
- Lupin to acquire established products in Europe, Canada from Sanofi for Rs 91 crLupin has acquired a portfolio of established products in Europe and Canada from Sanofi for a purchase consideration of EUR 10 million. The...
- Lupin Pharma partners with Endoceutics to commercialise Intrarosa in CanadaIntrarosa is Endoceutic's flagship product indicated for the treatment of postmenopausal vulvovaginal atrophy.
- Sun Pharma shuts 2 Gujarat R&D centres to cut costsSources said the company’s R&D centre at Gurgaon (started by erstwhile Ranbaxy) will now undertake the clinical research handled by the Vad...
- What spooked Sun Pharma stock in Monday’s tradeA total of 93 per cent of revenue of Sun Pharma’s US unit comes from US operations.
- As going gets tough, pharma firms revisit past decisionsCompanies have rationalised field force and restructured product portfolio to up productivity.
- Lupin looking to enter new product segments, geographies: MD Nilesh GuptaIn order to consolidate its business globally, the Mumbai-based firm has already inked various agreements in the previous fiscal.
- Lupin launches anti-bacterial Zaxine tablets in CanadaZaxine 550 mg (rifaximin) is a long-term antibiotic treatment drug for adults living with HE, a complication of liver disease (cirrhosis).
- Lupin ties up with Poland-based firm for generic asthama drugLupin has set up a dedicated centre of excellence for inhalation research in Florida after having hired top notch inhalation scientists las...
- Continuously evaluating opportunities for tie-ups with large MNCs: Ramesh Swaminathan, Lupin'We do keep talking to various big pharma companies for various kinds of alliance. So potentially I cannot speak about any deal until it ac...
- Lupin to set up two new R&D centres in USLupin had also increased research and development spending to Rs 958.28 crore in FY'14 as compared to Rs 770.85 crore in the FY'13.
- Venus Remedies to sell Meropenem in Australia; ties up with LupinVenus Remedies said it plans to roll out the drug by the third quarter of 2014 and is eyeing sizeable share in Australia's USD 15 million M...
- Ten stocks in focus in Friday morning tradeIndian markets are expected to trade in a range. Here is a list of ten stocks which are likely to be in focus in trade today.
- With attractive valuations, IT & pharma midcap stocks are worth a lookInvestors in technology and pharma sectors should partially book profits in largecap holdings and start investing their money in mid-cap st...
- Weak rupee to boost earnings of pharma exporters like Sun Pharma, Cipla, Dr Reddy's Labs, Cadila HealthcareHigher export realisations would help to enhance the overall performance of many companies in the sector for the current September quarter.
- GeNext to prescribe new growth formula for LupinDesh Bandhu Gupta built Lupin into a $1-billion enterprise, but he will chart the journey to $3 billion and beyond with his two children.
- Indian firms expect US FDA’s local office to speed up approvalsThe US Food and Drugs Administration’s new office in India could likely boost local pharma companies’ efforts to process their applications...
- Lupin wins Altace patent case in USIndia’s Lupin has won its patent challenge against King Pharmaceuticals and Sanofi-Aventis for blood pressure drug Altace, which has sales ...
Load More
